Daptomycin 4 mg/kg + Comparator: vancomycin + Daptomycin 6 mg/kg
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Staphylococcal Infection
Conditions
Staphylococcal Infection
Trial Timeline
Sep 1, 2008 → Feb 1, 2010
NCT ID
NCT00770341About Daptomycin 4 mg/kg + Comparator: vancomycin + Daptomycin 6 mg/kg
Daptomycin 4 mg/kg + Comparator: vancomycin + Daptomycin 6 mg/kg is a phase 3 stage product being developed by Merck for Staphylococcal Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00770341. Target conditions include Staphylococcal Infection.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00770341 | Phase 3 | Completed |
Competing Products
20 competing products in Staphylococcal Infection